Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
There is no confirmed gene or protein product named "cyclin Y like 7" (CCNYL7) in the scientific literature or major genetic databases. The name may result from a database error or misinterpretation of pseudogene nomenclature. Pseudogenes are genomic sequences that resemble functional genes but are not translated into proteins. While some pseudogenes can influence gene expression via regulatory RNAs, there is no evidence that "CCNYL7" has any such role, nor is it recognized as a therapeutic target. If the intended target is "Cyclin Y-like 1" (Ccnyl1) or "Cyclin Y" (Ccny), those are well-characterized cyclins involved in cell cycle regulation and Wnt signaling[1][3][4]. If the query is specifically about "CCNYL7," the entry should be considered incorrect or unsubstantiated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cyclin Y like 1 pseudogene 7 (CCNYL7).